Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in radical resection and endoprosthetic reconstruction
NCT04347122Phase 4Terminated
- Sponsor
- University of Kansas Medical Center
- Start
- Jan 2020
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in musculoskeletal cancer, soft tissue sarcoma (STS), sponsored by University of Kansas Medical Center. Started Jan 2020; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
musculoskeletal cancersoft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04347122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04347122.